Beckman Coulter in Research Project for Cardiovascular Disease Markers

Beckman Coulter is the industrial partner in a two-year research project to discover genetic signatures for cardiovascular disease (CVD) and obesity-related hypertension.

The company said it would have exclusive license to commercial application of the results, which will be used to develop content for the company’s molecular diagnostics platform.

“Molecular diagnostics will be a key growth area for Beckman Coulter in the coming years,” Bruce Wallace, vice president of the firm’s molecular diagnostics business center, said. “The discovery of genetic factors for both CVD and obesity may lead to development of readily accessible diagnostic tests.”